A systematic review of chronic fatigue syndrome: Don't assume it's depression

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 10, Issue 2, 2008, Pages 120-128

  Griffith, James P ^a   Zarrouf, Fahd A ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ANTIINFLAMMATORY AGENT; CARNITINE; CLONIDINE; CORTICOSTEROID; DULOXETINE; FLUDROCORTISONE; FLUOXETINE; HYDROCORTISONE; ICOSAPENTAENOIC ACID; MELATONIN; MOCLOBEMIDE; MODAFINIL; PLACEBO; PSYCHOSTIMULANT AGENT; RECOMBINANT ERYTHROPOIETIN; SELEGILINE; VENLAFAXINE;

CHRONIC FATIGUE SYNDROME; CLINICAL TRIAL; COGNITIVE THERAPY; COMBINATION CHEMOTHERAPY; DEPRESSION; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; ENDOCRINOLOGY; EVALUATION; EXERCISE; GENETIC ASSOCIATION; HUMAN; IMMUNOPATHOLOGY; INFECTION; LOW DRUG DOSE; MAJOR DEPRESSION; MEDLINE; MENTAL DISEASE; METABOLIC DISORDER; MOOD DISORDER; NEUROLOGIC DISEASE; PHOTOTHERAPY; PHYSICAL EXAMINATION; REVIEW;

EID: 45749140945     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/pcc.v10n0206     Document Type: Review

References (122)

1. Centers for Disease Control and Prevention. Chronic Fatigue Syndrome. May 26, 2006. Available at: www.cdc.gov/cfs. Accessed Feb 3, 2007
2. Wessely S. The epidemiology of chronic fatigue syndrome. Epidemiol Rev 1995;17:139-151
3. Schafer ML. On the history of the concept neurasthenia and its modern variants chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities [in German]. Fortschr Neurol Psychiatr 2002;70(11):570-582
4. Holmes GP, Kaplan JE, Gantz NM, et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med 1988;108:387-389
5. Lloyd AR, Wakefield D, Boughton C, et al. What is myalgic encephalomyelitis? Lancet 1988;1:1286-1287
6. Lloyd AR, Hickie I, Boughton CR, et al. Prevalence of chronic fatigue syndrome in an Australian population. Med J Aust 1990;153:522-528
7. Sharpe MC, Archard LC, Banatvala JE, et al. A report: chronic fatigue syndrome: guidelines for research. J R Soc Med 1991;84:118-121
8. Maquet D, Demoulin C, Crielaard JM. Chronic fatigue syndrome: a systematic review. Ann Readapt Med Phys 2006;49(6):337-347, 418-427
9. Lee S, Yu H, Wing Y, et al. Psychiatric morbidity and illness experience of primary care patients with chronic fatigue in Hong Kong. Am J Psychiatry 2000;157:380-384
10. Davis MP, Khoshknabi D, Yue GH. Management of fatigue in cancer patients. Curr Pain Headache Rep 2006;10(4):260-269
11. Pearce JM. The enigma of chronic fatigue. Eur Neurol 2006;56(1):31-36
12. Pichot P. Neurasthenia, yesterday and today [in French]. Encephale 1994;20 Spec No 3:545-549
13. Rangel L, Garralda ME, Jeffs J, et al. Family health and characteristics in chronic fatigue syndrome, juvenile rheumatoid arthritis, and emotional disorders of childhood. J Am Acad Child Adolesc Psychiatry 2005;44(2):150-158
14. Endicott NA. Chronic fatigue syndrome in private practice psychiatry: family history of physical and mental health. J Psychosom Res 1999;47(4):343-354
15. Buchwald D, Herrell R, Ashton S, et al. A twin study of chronic fatigue. Psychosom Med 2001;63(6):936-943
16. Hickie I, Kirk K, Martin N. Unique genetic and environmental determinants of prolonged fatigue: a twin study. Psychol Med 1999;29(2):259-268
17. Cho HJ, Skowera A, Cleare A, et al. Chronic fatigue syndrome: an update focusing on phenomenology and pathophysiology. Curr Opin Psychiatry 2006;19(1):67-73
18. Klimas NG, Salvato FR, Morgan R, et al. Immunologic abnormalities in the chronic fatigue syndrome. J Clin Microbiol 1990;28:1403-1410
19. Landay AL, Jessop C, Lennette ET, et al. Chronic fatigue syndrome: a clinical condition associated with immune activation. Lancet 1991;338:707-712
20. Robertson MJ, Schacterle RS, Mackin GA, et al. Lymphocyte subset differences in patients with chronic fatigue syndrome, multiple sclerosis and major depression. Clin Exp Immunol 2005;141(2):326-332
21. Lloyd A, Hickie I, Brockman A, et al. Cytokine levels in serum and cerebrospinal fluid in patients with chronic fatigue syndrome and control subjects. J Infect Dis 1991;164:1023-1024
22. Staines DR. Postulated vasoactive neuropeptide autoimmunity in fatigue-related conditions: a brief review and hypothesis. Clin Dev Immunol 2006;13(1):25-39
23. Byrne E. The chronic fatigue syndrome: a reappraisal and unifying hypothesis. Clin Exp Neurol 1991;28:128-138
24. Nakaya T, Kuratsune H, Kitani T, et al. Demonstration on Borna disease virus in patients with chronic fatigue syndrome [in Japanese]. Nippon Rinsho 1997;55(11):3064-3071
25. Li YJ, Wang DX, Bai XL, et al. Clinical characteristics of patients with chronic fatigue syndrome: analysis of 82 cases [in Chinese]. Zhonghua Yi Xue Za Zhi 2005;85(10):701-704
26. Matano S, Kinoshita H, Tanigawa K, et al. Acute parvovirus B19 infection mimicking chronic fatigue syndrome. Intern Med 2003;42(9):903-905
27. Kerr JR. Pathogenesis of parvovirus B19 infection: host gene variability, and possible means and effects of virus persistence. J Vet Med B Infect Dis Vet Public Health 2005;52(7-8):335-339
28. White PD, Thomas JM, Amess J, et al. Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever. Br J Psychiatry 1998;173:475-481
29. Chia JK. The role of enterovirus in chronic fatigue syndrome. J Clin Pathol 2005;58(11):1126-1132
30. Kondo K. Human herpesvirus latency and fatigue. Uirusu 2005;55(1):9-17
31. Komaroff AL. Chronic fatigue syndromes: a preliminary overview. Can Dis Wkly Rep 1991;17:23-28
32. Ablashi DV. Viral studies of chronic fatigue syndrome. Clin Infect Dis 1994;18(suppl 1):S130-S133
33. White PD, Thomas JM, Sullivan PF, et al. The nosology of sub-acute and chronic fatigue syndromes that follow infectious mononucleosis. Psychol Med 2004;34(3):499-507
34. Ng BY, Lim CC, Yeoh A, et al. Neuropsychiatric sequelae of Nipah virus encephalitis. J Neuropsychiatry Clin Neurosci 2004;16(4):500-504
35. Parker NR, Barralet JH, Bell AM. Q fever. Lancet 2006;367(9511):679-688
36. Masuda A, Nakayama T, Yamanaka T, et al. The prognosis after multidisciplinary treatment for patients with postinfectious chronic fatigue syndrome and noninfectious chronic fatigue syndrome. J Behav Med 2002;25(5):487-497
37. Wheatland R. Chronic ACTH autoantibodies are a significant pathological factor in the disruption of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome, anorexia nervosa and major depression. Med Hypotheses 2005;65(2):287-295
38. Gottschalk M, Kumpfel T, Flachenecker P, et al. Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis. Arch Neurol 2005 Feb;62(2):277-280
39. Wessely S. The neuropsychiatry of chronic fatigue syndrome. Ciba Found Symp 1993;173:212-229; discussion 229-237
40. Gaab J, Engert V, Heitz V, et al. Associations between neuroendocrine responses to the Insulin Tolerance Test and patient characteristics in chronic fatigue syndrome. J Psychosom Res 2004;56(4):419-424
41. Bakheit AM, Behan PO, Dinan TG, et al. Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome. BMJ 1992;304(6833):1010-1012
42. Inder WJ, Prickett TC, Mulder RT. Normal opioid tone and hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome despite marked functional impairment. Clin Endocrinol (Oxf) 2005;62(3):343-348
43. Durlach J, Pages N, Bac P, et al. Chronopathological forms of magnesium depletion with hypofunction or with hyperfunction of the biological clock. Magnes Res 2002;15(3-4):263-268
44. Kuratsune H, Yamaguti K, Sawada M, et al. Dehydroepiandrosterone sulfate deficiency in chronic fatigue syndrome. Int J Mol Med 1998;1(1):143-146
45. Nijs J, De Meirleir K. Impairments of the 2-5 synthetase/RNase L pathway in chronic fatigue syndrome. In Vivo 2005;19(6):1013-1021
46. Winkler AS, Blair D, Marsden JT, et al. Autonomic function and serum erythropoietin levels in chronic fatigue syndrome. J Psychosom Res 2004;56(2):179-183
47. Hatcher S, House A. Life events, difficulties and dilemmas in the onset of chronic fatigue syndrome: a case-control study. Psychol Med 2003;33(7):1185-1192
48. Taylor RR, Jason LA. Chronic fatigue, abuse-related traumatization, and psychiatric disorders in a community-based sample. Soc Sci Med 2002;55(2):247-256
49. Heim C, Wagner D, Maloney E, et al. Early adverse experience and risk for chronic fatigue syndrome: results from a population-based study. Arch Gen Psychiatry 2006;63(11):1258-1266
50. Morriss R, Sharpe M, Sharpley AL, et al. Abnormalities of sleep in patients with the chronic fatigue syndrome. BMJ 1993;306(6886):1161-1164
51. Morriss RK, Wearden AJ, Battersby L. The relation of sleep difficulties to fatigue, mood and disability in chronic fatigue syndrome. J Psychosom Res 1997;42(6):597-605
52. Friedlander AH, Mahler ME, Yagiela JA. Restless legs syndrome: manifestations, treatment and dental implications. J Am Dent Assoc 2006;137(6):755-761
53. Terman M, Levine SM, Terman JS, et al. Chronic fatigue syndrome and seasonal affective disorder: comorbidity, diagnostic overlap, and implications for treatment. Am J Med 1998;105(3A):115S-124S
54. Ghahramani M, Gooriah V. Chronic fatigue syndrome associated with a psychotic state resulting in multiple murders. Bull Am Acad Psychiatry Law 1995;23(4):613-616
55. Skapinakis P, Lewis G, Mavreas V. Unexplained fatigue syndromes in a multinational primary care sample: specificity of definition and prevalence and distinctiveness from depression and generalized anxiety. Am J Psychiatry 2003;160:785-787
56. Hawk C, Jason LA, Torres-Harding S. Differential diagnosis of chronic fatigue syndrome and major depressive disorder. Int J Behav Med 2006;13(3):244-251
57. Moldofsky H. Nonrestorative sleep and symptoms after a febrile illness in patients with fibrositis and chronic fatigue syndromes. J Rheumatol Suppl 1989;19:150-153
58. Dendy C, Cooper M, Sharpe M. Interpretation of symptoms in chronic fatigue syndrome. Behav Res Ther 2001;39(11):1369-1380
59. Moss-Morris R, Petrie KJ. Discriminating between chronic fatigue syndrome and depression: a cognitive analysis. Psychol Med 2001;31(3):469-479
60. White PD, Pinching AJ, Rakib A, et al. A comparison of patients with chronic fatigue syndrome attending separate fatigue clinics based in immunology and psychiatry. J R Soc Med 2002;95(9):440-444
61. David AS. Postviral fatigue syndrome and psychiatry. Br Med Bull 1991;47(4):966-988
62. Fulcher KY, White PD. Strength and physiological response to exercise in patients with chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 2000;69(3):302-307
63. Lawrie SM, MacHale SM, Cavanagh JT, et al. The difference in patterns of motor and cognitive function in chronic fatigue syndrome and severe depressive illness. Psychol Med 2000;30(2):433-442
64. Scott LV, Salahuddin F, Cooney J, et al. Differences in adrenal steroid profile in chronic fatigue syndrome, in depression and in health. J Affect Disord 1999;54(1-2):129-137
65. Sharpe M, Chalder T, Palmer I, et al. Chronic fatigue syndrome: a practical guide to assessment and management. Gen Hosp Psychiatry 1997;19(3):185-199
66. Glass JM. Cognitive dysfunction in fibromyalgia and chronic fatigue syndrome: new trends and future directions. Curr Rheumatol Rep 2006;8(6):425-429
67. Geisser ME, Gracely RH, Giesecke T, et al. The association between experimental and clinical pain measures among persons with fibromyalgia and chronic fatigue syndrome. Eur J Pain 2007;11(2):202-207
68. Yunus MB. Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes. Semin Arthritis Rheum 2007;36(6):339-356
69. Brown MM, Jason LA. Functioning in individuals with chronic fatigue syndrome: increased impairment with co-occurring multiple chemical sensitivity and fibromyalgia. Dyn Med 2007;6:9
70. Cook DB, Nagelkirk PR, Poluri A, et al. The influence of aerobic fitness and fibromyalgia on cardiorespiratory and perceptual responses to exercise in patients with chronic fatigue syndrome. Arthritis Rheum 2006;54(10):3351-3362
71. Matsumoto Y. Fibromyalgia syndrome. Nippon Rinsho 1999;57(2):364-369
72. Naschitz JE, Rosner I, Rozenbaum M, et al .The head-up tilt test with haemodynamic instability score in diagnosing chronic fatigue syndrome. QJM 2003;96(2):133-142
73. Gallagher AM, Coldrick AR, Hedge B, et al. Is the chronic fatigue syndrome an exercise phobia? a case control study. J Psychosom Res 2005;58(4):367-373
74. Marshall GS, Gesser RM, Yamanishi K, et al. Chronic fatigue in children: clinical features, Epstein-Barr virus and human herpesvirus 6 serology and long term follow-up. Pediatr Infect Dis J 1991;10(4):287-290
75. Buchwald D, Wener MH, Pearlman T, et al. Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome. J Rheumatol 1997;24(2):372-376
76. Swanink CM, Vercoulen JH, Bleijenberg G, et al. Chronic fatigue syndrome: a clinical and laboratory study with a well matched control group. J Intern Med 1995;237(5):499-506
77. Natelson BH, Cohen JM, Brassloff I, et al. A controlled study of brain magnetic resonance imaging in patients with the chronic fatigue syndrome. J Neurol Sci 1993;120(2):213-217
78. Cope H, Pernet A, Kendall B, et al. Cognitive functioning and magnetic resonance imaging in chronic fatigue. Br J Psychiatry 1995;167(1):86-94
79. Greco A, Tannock C, Brostoff J, et al. Brain MR in chronic fatigue syndrome. AJNR Am J Neuroradiol 1997;18(7):1265-1269
80. Lange G, DeLuca J, Maldjian JA, et al. Brain MRI abnormalities exist in a subset of patients with chronic fatigue syndrome. J Neurol Sci 1999;171(1):3-7
81. Cook DB, Lange G, DeLuca J, et al. Relationship of brain MRI abnormalities and physical functional status in chronic fatigue syndrome. Int J Neurosci 2001;107(1-2):1-6
82. Lange G, Holodny AI, DeLuca J, et al. Quantitative assessment of cerebral ventricular volumes in chronic fatigue syndrome. Appl Neuropsychol 2001;8(1):23-30
83. de Lange FP, Kalkman JS, Bleijenberg G, et al. Gray matter volume reduction in the chronic fatigue syndrome. Neuroimage 2005;26(3):777-781
84. Daugherty SA, Henry BE, Peterson DL, et al. Chronic fatigue syndrome in northern Nevada. Rev Infect Dis 1991;13(suppl 1):S39-S44
85. Caseras X, Mataix-Cols D, Giampietro V, et al. Probing the working memory system in chronic fatigue syndrome: a functional magnetic resonance imaging study using the n-back task. Psychosom Med 2006;68(6):947-955
86. Tanaka M, Sadato N, Okada T, et al. Reduced responsiveness is an essential feature of chronic fatigue syndrome: a fMRI study. BMC Neurol 2006;6:9
87. Lange G, Steffener J, Cook DB, et al. Objective evidence of cognitive complaints in chronic fatigue syndrome: a BOLD fMRI study of verbal working memory. Neuroimage 2005;26(2):513-524
88. Okada T, Tanaka M, Kuratsune H, et al. Mechanisms underlying fatigue: a voxel-based morphometric study of chronic fatigue syndrome. BMC Neurol 2004;4(1):14
89. de Lange FP, Kalkman JS, Bleijenberg G, et al. Neural correlates of the chronic fatigue syndrome: an fMRI study [published online ahead of print July 7, 2004]. Brain 2004;127(pt 9):1948-1957. doi:10.1093/brain/awh225
90. Goldstein J. Chronic Fatigue Syndrome: The Struggle for Health. Beverly Hills, Calif: Chronic Fatigue Syndrome Institute; 1990
91. Schwartz RB, Garada BM, Komaroff AL, et al. Detection of intracranial abnormalities in patients with chronic fatigue syndrome: comparison of MR imaging and SPECT. AJR Am J Roentgenol 1994;162(4):935-941
92. Siessmeier T, Nix WA, Hardt J, et al. Observer independent analysis of cerebral glucose metabolism in patients with chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 2003;74(7):922-928
93. Yamamoto S, Ouchi Y, Onoe H, et al. Reduction of serotonin transporters of patients with chronic fatigue syndrome. Neuroreport 2004;15(17):2571-2574
94. Puri BK. Proton and 31-phosphorus neurospectroscopy in the study of membrane phospholipids and fatty acid intervention in schizophrenia, depression, chronic fatigue syndrome (myalgic encephalomyelitis) and dyslexia. Int Rev Psychiatry 2006;18(2):145-147
95. Wang Q, Xiong JX. Clinical observation on electroacupuncture for treatment of chronic fatigue syndrome [in Chinese]. Zhongguo Zhen Jiu 2005;25(10):691-692
96. Price JR, Couper J. Cognitive behaviour therapy for adults with chronic fatigue syndrome. Cochrane Database Syst Rev 2000;2:CD001027
97. Akagi H, Klimes I, Bass C. Cognitive behavioral therapy for chronic fatigue syndrome in a general hospital: feasible and effective. Gen Hosp Psychiatry 2001;23(5):254-260
98. Deale A, Husain K, Chalder T, et al. Long-term outcome of cognitive behavior therapy versus relaxation therapy for chronic fatigue syndrome: a 5-year follow-up study. Am J Psychiatry 2001;158:2038-2042
99. Deale A, Chalder T, Marks I, et al. Cognitive behavior therapy for chronic fatigue syndrome: a randomized controlled trial. Am J Psychiatry 1997;154:408-414
100. Masuda A, Nakayama T, Yamanaka T, et al. Cognitive behavioral therapy and fasting therapy for a patient with chronic fatigue syndrome. Intern Med 2001;40(11):1158-1161
101. O'Dowd H, Gladwell P, Rogers CA, et al. Cognitive behavioural therapy in chronic fatigue syndrome: a randomised controlled trial of an outpatient group programme. Health Technol Assess 2006;10(37):iii-iv, ix-x, 1-121
102. Coutts R, Weatherby R, Davie A. The use of a symptom "self- report" inventory to evaluate the acceptability and efficacy of a walking program for patients suffering with chronic fatigue syndrome. J Psychosom Res 2001;51(2):425-429
103. Fulcher KY, White PD. Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome. BMJ 1997;314(7095):1647-1652
104. Friedberg F. Does graded activity increase activity? a case study of chronic fatigue syndrome. J Behav Ther Exp Psychiatry 2002;33(3-4):203-215
105. Powell P, Bentall RP, Nye FJ, et al. Patient education to encourage graded exercise in chronic fatigue syndrome: 2-year follow-up of randomised controlled trial. Br J Psychiatry 2004;184:142-146
106. Goodnick PJ, Sandoval R. Psychotropic treatment of chronic fatigue syndrome and related disorders. J Clin Psychiatry 1993;54:13-20
107. Natelson BH, Cheu J, Hill N, et al. Single-blind, placebo phase-in trial of two escalating doses of selegiline in the chronic fatigue syndrome. Neuropsychobiology 1998;37(3):150-154
108. Klimas NG, Morgan R, Van Rid F, et al. Observations regarding use of an antidepressant, fluoxetine, in chronic fatigue syndrome. In: Goodnick PJ, Klimas NG, eds. Chronic Fatigue and Related Immune Deficiency Syndromes. Washington, DC: American Psychiatric Press; 1993:95-108
109. Vercoulen JH, Swanink CM, Zitman FG, et al. Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet 1996;347(9005):858-861
110. Wearden AJ, Morriss RK, Mullis R, et al. Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome. Br J Psychiatry 1998;172:485-490
111. Goodnick PJ, Sandoval R, Brickman A, et al. Bupropion treatment of fluoxetine-resistant chronic fatigue syndrome. Biol Psychiatry 1992;32:834-838
112. Schonfeldt-Lecuona C, Connemann BJ, Wolf RC, et al. Bupropion augmentation in the treatment of chronic fatigue syndrome with coexistent major depression episode [letter]. Pharmacopsychiatry 2006;39(4):152-154
113. Lecrubien Y. Antidepressant drugs: similar but different? In: Mendlewicz J, Brunello N, Langer SZ, et al, eds. New Pharmacological Approaches to the Therapy of Depressive Disorders. Basel, Switzerland: Karger; 1993:83-91
114. White PD, Cleary KJ. An open study of the efficacy and adverse effects of moclobemide in patients with the chronic fatigue syndrome. Int Clin Psychopharmacol 1997;12(1):47-52
115. Morriss RK, Robson MJ, Deakin JF. Neuropsychological performance and noradrenaline function in chronic fatigue syndrome under conditions of high arousal. Psychopharmacology (Berl) 2002;163(2):166-173
116. Cleare AJ, O'Keane V, Miell J. Plasma leptin in chronic fatigue syndrome and a placebo-controlled study of the effects of low-dose hydrocortisone on leptin secretion. Clin Endocrinol (Oxf) 2001;55(1):113-119
117. Puri BK, Holmes J, Hamilton G. Eicosapentaenoic acid-rich essential fatty acid supplementation in chronic fatigue syndrome associated with symptom remission and structural brain changes. Int J Clin Pract 2004;58(3):297-299
118. Laviano A, Meguid MM, Guijarro A, et al. Antimyopathic effects of carnitine and nicotine. Curr Opin Clin Nutr Metab Care 2006;9(4):442-448
119. Randall DC, Cafferty FH, Shneerson JM, et al. Chronic treatment with modafinil may not be beneficial in patients with chronic fatigue syndrome. J Psychopharmacol 2005;19(6):647-660
120. McDermott C, Richards SC, Thomas PW, et al. A placebo-controlled, double-blind, randomized controlled trial of a natural killer cell stimulant (BioBran MGN-3) in chronic fatigue syndrome. QJM 2006;99(7):461-468
121. Blockmans D, Persoons P, Van Houdenhove B, et al. Combination therapy with hydrocortisone and fludrocortisone does not improve symptoms in chronic fatigue syndrome: a randomized, placebo-controlled, double-blind, crossover study. Am J Med 2003;114(9):736-741
122. Williams G, Waterhouse J, Mugarza J, et al. Therapy of circadian rhythm disorders in chronic fatigue syndrome: no symptomatic improvement with melatonin or phototherapy. Eur J Clin Invest 2002;32(11):831-837